P
Prilenia
1 follower
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders.
Org chart
Michael R. Hayden
Collapse
Henk Schuring
Chief Regulatory & Commercialization Officer
Anne Sullivan
Chief Business Officer
Yael Cohen
SVP, Head of Clinical Operations
Elena Berelovich
SVP, Head of CMC
Michal Geva
SVP, Head of Research
Rob Lauzen
Chief Financial Officer
Kristina Coppola
Head Of Corporate Communications
Board & advisors
Geert-Jan Mulder
Board Member
Stefan Larson
Board Member
R. Blane Walter
Board Member
Jason R. Dinges
Board Member
Michael Ginder
Director
Nikola Trbovic
Director
Offices
Similar companies
Vaxcyte
2 followers
Day One Biopharmaceuticals
1 follower
Compugen
1 follower
Cardurion Pharmaceuticals
1 follower
Thermo Fisher Scientific
183 followers
Gilead Sciences
139 followers
Vertex Pharmaceuticals
67 followers
Illumina
73 followers
Agilent Technologies
74 followers
Neuralink
64 followers
BioMarin Pharmaceutical
38 followers
Explore companies